Please login to your online account to display your discounted pricing

IL-6 Mouse anti-Human, Clone: 6708, R&D Systems


Mouse Monoclonal Antibody

Manufacturer: r & d systems  MAB206500

 View more versions of this product

Catalog No. MAB206500

  • / Each
 

Description & Specifications

Specifications

Antigen IL-6
Applications ELISA Capture
Applications Neutralization
Applications Western Blot
Clone 6708
Conjugate Unlabeled
Format Purified
Format Supernatant
Formulation Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. &asterisk;Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS.
Host Species Murine
Immunogen E. coli-derived recombinant human IL-6
Isotype IgG1
Quantity 500μg
Regulatory Status RUO
Storage Requirements 2° to 8°C under sterile conditions after reconstitution; 6 months, −20° to −70°C under sterile conditions. Avoid repeated freeze-thaw cycles.
Primary or Secondary Primary
Monoclonal or Polyclonal Monoclonal
Gene ID (Entrez) 3569
Test Specificity Detects human IL-6 in ELISAs and Western blots. In Western blots, this antibody does not cross-react with recombinant mouse (rm) IL-6, rhOSM, rhLIF, rhIL-11, rhgp130, or rhCNTF.
Reconstitution Reconstitute at 0.5mg/mL in sterile PBS.
Target Species Human

Interleukin 6 (IL-6) is a pleiotropic α-helical cytokine that plays important roles in acute phase reactions, inflammation, hematopoiesis, bone metabolism, and cancer progression. IL-6 activity is essential for the transition from acute inflammation to either acquired immunity or chronic inflammatory disease. It is secreted by multiple cell types as a 22-28kDa phosphorylated and variably glycosylated molecule (1-4). Mature human IL-6 is 183 amino acids (aa) in length and shares 41% aa sequence identity with mouse and rat IL-6 (5). Alternate splicing generates several isoforms with internal deletions, some of which exhibit antagonistic properties (6-9). Human IL-6 is equally active on mouse and rat cells (10). IL-6 induces signaling through a cell surface heterodimeric receptor complex composed of a ligand binding subunit (IL-6 R) and a signal transducing subunit (gp130). IL-6 binds to IL-6 R, triggering IL-6 R association with gp130 and gp130 dimerization (11). gp130 is also a component of the receptors for CLC, CNTF, CT-1, IL-11, IL-27, LIF, and OSM (12). Soluble forms of IL-6R are generated by both alternate splicing and proteolytic cleavage (3). In a mechanism known as trans-signaling, complexes of soluble IL-6 and IL-6 R elicit responses from gp130-expressing cells that lack cell surface IL-6 R (3).
Trans-signaling enables a wider range of cell types to respond to IL-6, as the expression of gp130 is ubiquitous, while that of IL-6 R is predominantly restricted to hepatocytes, leukocytes, and lymphocytes (3). Soluble splice forms of gp130 block trans-signaling from IL-6/IL-6 R but not from other cytokines that utilize gp130 as a coreceptor (4, 13).